NCT00104507View on ClinicalTrials.gov

Safety and Efficacy of APD356 in the Treatment of Obesity

PHASE2CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

May 31, 2005

Conditions

Obesity

Interventions

DRUG

APD356

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00104507 - Safety and Efficacy of APD356 in the Treatment of Obesity | Biotech Hunter | Biotech Hunter